|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-8-24
|
|
pubmed:abstractText |
Dosing of most drugs must be adapted in renal insufficiency, making accurate assessment of renal function essential in clinical medicine. Furthermore, even modest impairment of renal function has been recognized as a cardiovascular risk factor. The purpose of this analysis was to identify the role of symmetric dimethylarginine (SDMA), the structural isomer of the cardiovascular risk marker asymmetric dimethylarginine, as an endogenous marker of renal function.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2446-51
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16766542-Arginine,
pubmed-meshheading:16766542-Biological Markers,
pubmed-meshheading:16766542-Cardiovascular Diseases,
pubmed-meshheading:16766542-Creatinine,
pubmed-meshheading:16766542-Female,
pubmed-meshheading:16766542-Humans,
pubmed-meshheading:16766542-Inulin,
pubmed-meshheading:16766542-Male,
pubmed-meshheading:16766542-Prognosis,
pubmed-meshheading:16766542-Renal Insufficiency, Chronic,
pubmed-meshheading:16766542-Retrospective Studies,
pubmed-meshheading:16766542-Risk Factors
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis.
|
|
pubmed:affiliation |
Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5406, USA. Kielstein@yahoo.com.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
